Given the peculiarities of the pharmaceutical sector and its wide exposure to ESG factors, this chapter aims to verify the possible presence and the strength of a relationship between firms ESG scores and their economic-financial performance. We consider a benchmark sample of 103 pharmaceutical companies listed around the world, exhibiting ESG scores from 2004 to 2018. Firstly, results showed that the governance score has a negative impact on ROA and a positive impact on Tobin's Q. Secondly, considering the firm size, all the ESG scores on which research hypotheses were tested gain statistical significance. In particular, for smaller pharmaceutical companies, both the governance and controversies score have a negative impact on ROA. While, as the firm size grows, the controversies score has a positive impact on both ROA and Tobin's Q. Finally, there is an inverted U-shaped non-linear relationship between ESG scores and Tobin’s Q.

(2022). How Much Does Matter ESG Ratings in Big Pharma Firms Performances? . Retrieved from https://hdl.handle.net/10446/249935

How Much Does Matter ESG Ratings in Big Pharma Firms Performances?

Pellegrini, Laura
2022-01-01

Abstract

Given the peculiarities of the pharmaceutical sector and its wide exposure to ESG factors, this chapter aims to verify the possible presence and the strength of a relationship between firms ESG scores and their economic-financial performance. We consider a benchmark sample of 103 pharmaceutical companies listed around the world, exhibiting ESG scores from 2004 to 2018. Firstly, results showed that the governance score has a negative impact on ROA and a positive impact on Tobin's Q. Secondly, considering the firm size, all the ESG scores on which research hypotheses were tested gain statistical significance. In particular, for smaller pharmaceutical companies, both the governance and controversies score have a negative impact on ROA. While, as the firm size grows, the controversies score has a positive impact on both ROA and Tobin's Q. Finally, there is an inverted U-shaped non-linear relationship between ESG scores and Tobin’s Q.
2022
Barbieri, Sophia Veronica; Pellegrini, Laura
File allegato/i alla scheda:
File Dimensione del file Formato  
2022capitolo di libro Palgrave_Laura Pellegrini_ridotto.pdf

Solo gestori di archivio

Versione: publisher's version - versione editoriale
Licenza: Licenza default Aisberg
Dimensione del file 9.39 MB
Formato Adobe PDF
9.39 MB Adobe PDF   Visualizza/Apri
Pubblicazioni consigliate

Aisberg ©2008 Servizi bibliotecari, Università degli studi di Bergamo | Terms of use/Condizioni di utilizzo

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10446/249935
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact